Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Mechanism of Pharmacological Action”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05343637
What this trial is testing

A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Respira Therapeutics, Inc. 14
Large-scale testing (Phase 3)Ended earlyNCT01123161
What this trial is testing

The Intravascular Cooling in the Treatment of Stroke 2/3 Trial

Who this might be right for
Stroke, Acute
University of California, San Diego 120
Large-scale testing (Phase 3)Looking for participantsNCT05105633
What this trial is testing

Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke

Who this might be right for
Basilar Artery Occlusion
University of Melbourne 688
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Post-approval studies (Phase 4)Study completedNCT02695992
What this trial is testing

Rate Control in Atrial Fibrillation II

Who this might be right for
Atrial FibrillationPermanent Atrial Fibrillation
Asker & Baerum Hospital 122
Testing effectiveness (Phase 2)Study completedNCT04722887
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

Who this might be right for
Alpha1-Antitrypsin Deficiency
Grifols Therapeutics LLC 17
Post-approval studies (Phase 4)Study completedNCT01385631
What this trial is testing

Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.

Who this might be right for
ST-Segment Elevation Myocardial Infarction
Odense University Hospital 87
Testing effectiveness (Phase 2)Study completedNCT03150862
What this trial is testing

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
BeiGene USA, Inc. 116
Testing effectiveness (Phase 2)WithdrawnNCT05991232
What this trial is testing

Repeated Neurocognitive Measurements in Depressed Patients

Who this might be right for
Depression, Unipolar
Jay Fournier
Early research (Phase 1)Looking for participantsNCT06796361
What this trial is testing

Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness

Who this might be right for
Healthy
University Hospital, Basel, Switzerland 16
Post-approval studies (Phase 4)Study completedNCT06314763
What this trial is testing

Rivaroxaban Sotorasib Interaction Study

Who this might be right for
Drug Drug Interaction Study
Radboud University Medical Center 21
Large-scale testing (Phase 3)Study completedNCT01024413
What this trial is testing

Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations

Who this might be right for
Thoracic Neoplasms
Chinese Society of Lung Cancer 256
Testing effectiveness (Phase 2)Study completedNCT03349450
What this trial is testing

DPX-Survivac and Checkpoint Inhibitor in DLBCL

Who this might be right for
Adult Diffuse Large Cell LymphomaRecurrentAdult Refractory Diffuse Large B-Cell Lymphoma
Sunnybrook Health Sciences Centre 25
Testing effectiveness (Phase 2)Study completedNCT00050440
What this trial is testing

Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma

Who this might be right for
Endometrial NeoplasmsUterine NeoplasmsGenital Neoplasms, Female Urogenital Neoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 50
Testing effectiveness (Phase 2)Study completedNCT05697809
What this trial is testing

Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Oxular Limited 3
Testing effectiveness (Phase 2)Looking for participantsNCT06511908
What this trial is testing

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

Who this might be right for
SuicideDepressive Disorder, Treatment-ResistantKetamine+10 more
National Institute of Mental Health (NIMH) 50
Early research (Phase 1)UnknownNCT04161404
What this trial is testing

Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting Condition

Who this might be right for
PharmacokineticsMolecular Mechanisms of Pharmacological Action
University of Malaya 18
Large-scale testing (Phase 3)Study completedNCT04368559
What this trial is testing

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

Who this might be right for
CandidemiaMycosesFungal Infection+7 more
Mundipharma Research Limited 602
Not applicableStudy completedNCT05750446
What this trial is testing

Effect of Riocigaut on Migraine Attack Induction in People With Migraine

Who this might be right for
Migraine Without Aura
Danish Headache Center 22
Testing effectiveness (Phase 2)Looking for participantsNCT06463665
What this trial is testing

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Who this might be right for
Advanced Non-squamous Non-small-cell Lung CancerAdvanced Squamous Non-Small Cell Lung CarcinomaMetastatic Non-squamous Non Small Cell Lung Cancer+5 more
Genelux Corporation 142
Next Page